Clifton Springs Hospital & Clinic

Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis - ResearchAndMarkets.com

Retrieved on: 
星期四, 十一月 9, 2023
Health, Pharmaceutical, Stroke, Allergy, Headache, Incidence, Thrombosis, Vomiting, Laboratory, Prevalence, Face, Myocardial infarction, Pfizer, Clifton Springs Hospital & Clinic, Research, Bleeding, Nausea, Venous thrombosis, Pulmonary embolism, Abbott Laboratories, Fever, Chest pain, Deep vein thrombosis, DVT, Common, Geography, Marketing, Hospital, Atomic mass, Coagulopathy, Merck Group, Wilford Hall Ambulatory Surgical Center, Intracerebral hemorrhage, USD, Blood, Safety, Patient, Cardiovascular disease, COVID-19, Pharmaceutical industry, Birth control

The "Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The urokinase market is being driven by the increasing prevalence of pulmonary embolism (PE), a condition characterized by blood clots in the lungs.
  • Urokinase, a thrombolytic agent, is used to dissolve these clots and is naturally produced by the human body.
  • The urokinase market is highly competitive, featuring numerous players involved in developing and marketing urokinase products.

Advanced wound care market to grow by USD 4.02 million from 2022 to 2027|3M Co., 4L Health Co. Ltd., Anika Therapeutics Inc., Cardinal Health Inc., Carilex Medical Inc. and more among the key companies - Technavio

Retrieved on: 
星期四, 十一月 9, 2023
Ageing, Incidence, Burns, 3M, Smith, Prevalence, Conditional sentence, Eastman Kodak Co. v. Image Technical Services, Inc., ROW, Coloplast, Hyaluronic acid, Quality of life, Tissue, CDC, Growth, Lohmann, Medline Industries, Risk, Hospital, Telehealth, Cardinal Health, HOB GmbH & Co KG, Clifton Springs Hospital & Clinic, USD, NPWT, Cancer, Patient, Burn, Education minister, Medtronic, Wound healing, Pharmaceutical industry, Nursing, Pet industry, Geography, COVID-19

The global advanced wound care market is fragmented, with the presence of several global as well as regional vendors.

Key Points: 
  • The global advanced wound care market is fragmented, with the presence of several global as well as regional vendors.
  • 3M Co. - This company offers various products under its wound care segment, such as wound care dressings, compression systems and wraps, medical tapes, wound cleansers, wound closure, barriers, creams, and lotions.
  • By geography, the global advanced wound care market is segmented into North America, Europe, Asia, and Rest of World (ROW).
  • The increasing use of telemedicine in wound care treatments is an emerging advanced wound care market trend.

Hospital Inpatient Care Dominates Palliative Care Market as Specialized Services Gain Traction - ResearchAndMarkets.com

Retrieved on: 
星期三, 十一月 1, 2023
Health, Hospitals, Age, Nursing home, Heart, Central nervous system disease, Vomiting, Prevalence, Conditional sentence, Clifton Springs Hospital & Clinic, Diabetes, CNS, Incidence, Nausea, Vels Institute of Science, Technology & Advanced Studies, Quality of life, Growth, Caregiver, COVID-19, Asthma, Hospital, Telehealth, Arthritis, Anxiety, Alzheimer's disease, Pain, Patient, Hospice, COPD, CHF, Health care, Nursing, Residential care, Dementia, Palliative care, Cancer

By Type: The global palliative care market encompasses five key segments: Hospital Inpatient Care, Hospice Inpatient Care, Nursing Home, Residential Facility Center, and Others.

Key Points: 
  • By Type: The global palliative care market encompasses five key segments: Hospital Inpatient Care, Hospice Inpatient Care, Nursing Home, Residential Facility Center, and Others.
  • Hospital inpatient care holds the largest market share and is anticipated to experience significant growth, driven by the increasing availability of specialized palliative care services within hospitals.
  • By End-User: Palliative care services are provided through various end-users, including Hospitals & Clinics, Home Care Settings, Palliative Care Centers, and Others.
  • Lack of Access to Palliative Care Services in Underdeveloped Countries: Inadequate access to palliative care services in underdeveloped regions presents a significant challenge to market expansion.

Key Drivers of Growth in Orthopedic Regenerative Surgical Products Market: Aging Population and Technological Innovations - ResearchAndMarkets.com

Retrieved on: 
星期一, 十月 30, 2023
Surgery, Health, FDA, Ageing, IND, Korea Disease Control and Prevention Agency, Obesity, Abdominal ultrasonography, Prevalence, Umbilical cord, Arthralgia, R, Trauma, Application, Allotransplantation, CDC, Growth, COVID-19, Risk, Hospital, Osteoarthritis, Fibromyalgia, USD, Therapy, Clifton Springs Hospital & Clinic, Pain, Gout, Arthritis, Pharmaceutical industry

The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.63 billion by 2030.

Key Points: 
  • The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.63 billion by 2030.
  • The primary factors boosting the market growth include the growing older population, easy availability of orthopedic treatments & procedures, and technological advancements.
  • For instance, osteoarthritis, an orthopedic ailment, has been considered the major factor of chronic disability in the geriatric population (aged above 70 years).
  • Thus, the growing prevalence of orthopedic ailments and the rising aging population & obesity cases are expected to drive market growth.

Implantable Medical Devices Market to grow by USD 51.1 billion from 2022-2027 | North America to account for 45% of market growth - Technavio

Retrieved on: 
星期二, 九月 26, 2023
LivaNova, Prevalence, Osteoporosis, Abbott Laboratories, Tetraplegia, Segment, National Center for Spinal Disorders, SE, Stryker Corporation, Rheumatoid arthritis, Dental implant, Gout, Hip, Zimmer Biomet, Lupus, Cardinal Health, USD, CDC, Medial knee injuries, Boston Scientific, Circulatory system, Growth, Assurant, Orthopedic surgery, Trauma, Clifton Springs Hospital & Clinic, Arthritis, Hospital, NuVasive, Research, Arthropathy, Knee, Laboratory, AbbVie, Ophthalmic, ROW, Korea Disease Control and Prevention Agency, Fibromyalgia, Medtronic, Medical device, Retail, Application, Geography

NEW YORK, Sept. 25, 2023 /PRNewswire/ -- The implantable medical devices market size is expected to grow by USD 51.1 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, Sept. 25, 2023 /PRNewswire/ -- The implantable medical devices market size is expected to grow by USD 51.1 billion from 2022 to 2027.
  • Hence, such factors drive the growth of the implantable medical devices market during the forecast period.
  • Detailed information on factors that will drive the growth of the implantable medical devices market between 2022 and 2027.
  • Growth of the implantable medical devices market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of implantable medical devices market vendors.

Blood Pressure Transducers Market to grow by USD 128.65 million from 2022 to 2027, North America to account for 36% of market growth- Technavio

Retrieved on: 
星期三, 九月 20, 2023
Prevalence, Maharashtra University of Health Sciences, MHealth, Patient, EHR, Masimo, Hospice and palliative medicine, Telehealth, Clinical data management, UGO, Reusability, Attention, USD, Hypertension, BP, Growth, Diagnosis, Clifton Springs Hospital & Clinic, Disposable product, Hospital, Biotechnology, HOB GmbH & Co KG, FREE, Edwards Lifesciences, Research, Blood pressure, ROW, Abdominal ultrasonography, Pharmaceutical industry, Medical device, Geography

NEW YORK, Sept. 20, 2023 /PRNewswire/ -- The blood pressure transducers market is expected to grow by USD 128.65 million from 2022 to 2027.

Key Points: 
  • NEW YORK, Sept. 20, 2023 /PRNewswire/ -- The blood pressure transducers market is expected to grow by USD 128.65 million from 2022 to 2027.
  • The market is segmented by Product (Disposable blood pressure transducers and Reusable blood pressure transducers), End-user (Hospitals, Clinics, and ASCs), and Geography (North America, Europe, Asia, and the Rest of the World (ROW)).
  • Some of the key countries that are contributing significantly to the growth of the blood pressure (BP) probe market in North America are the US and Canada.
  • Growth of the blood pressure transducers market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of the blood pressure transducer market companies.

Insulin Pumps Segment Projected to Lead Growth in Global Insulin Delivery Devices Market to 2028, with a CAGR of 8.5% by 2028 - ResearchAndMarkets.com

Retrieved on: 
星期三, 九月 13, 2023
Medical Supplies, Biotechnology, Manufacturing, Other Consumer, Diabetes, Health, Health Technology, Medical Devices, Other Manufacturing, Hospitals, Consumer, Prevalence, Disposable product, Tether, Hospital, USD, Developed country, Growth, Clifton Springs Hospital & Clinic, Medical device, Pharmaceutical industry, Safety

The global insulin delivery devices market is projected to reach USD 46.2 billion by 2028 from USD 30.8 billion in 2023, at a CAGR of 8.5% during the forecast period.

Key Points: 
  • The global insulin delivery devices market is projected to reach USD 46.2 billion by 2028 from USD 30.8 billion in 2023, at a CAGR of 8.5% during the forecast period.
  • Growth in the insulin delivery devices market is mainly driven by factors such as the growing prevalence of diabetic population, government support and favourable reimbursement schemes, technological advancements in insulin delivery devices.
  • Insulin pumps segment is projected to grow at the highest CAGR during the forecast period By type, the global insulin delivery devices market is segmented into insulin pens, insulin pumps, insulin pen needles, insulin syringes and other insulin delivery devices which includes, transdermal insulin patch, insulin jet injectors, insulin inhalers.
  • By region, North America is projected to account for the largest share of the insulin delivery devices market.

Medivir Hosts Expert Perspectives Webcast on the Evolving Treatment Landscape and the Unique Treatment Challenges in HCC

Retrieved on: 
星期五, 九月 1, 2023
AME Publishing Company, Lead, University, Medivir, Clifton Springs Hospital & Clinic, Cancer, DRS, Reig, Oncology, BCLC, Research, CMO, Cancer Science, Defence Scientific Advisory Council, ECMC, University of Glasgow, Liver cancer, Patient, School, Dr. Evan Alexander Erwin House, Webcast, Hospital, HCC, Lenvatinib, Disease, Pharmaceutical industry, Medical device, Beatson West of Scotland Cancer Centre

The webcast will feature presentations by Dr. Jeff Evans, Beatson West of Scotland Cancer Center, Glasgow, UK, who will discuss the current treatment landscape and unmet medical need in treating patients with HCC.

Key Points: 
  • The webcast will feature presentations by Dr. Jeff Evans, Beatson West of Scotland Cancer Center, Glasgow, UK, who will discuss the current treatment landscape and unmet medical need in treating patients with HCC.
  • He will be joined by Dr. Maria Reig, Liver Cancer Unit, Hospital Clínic BCLC group, Villarroel, Barcelona, Spain, who will discuss how HCC is different from many other tumor types and its unique treatment challenges.
  • Both Drs are investigators in the phase 1b/2a study with fostrox in combination with Lenvima and will also share their perspectives from the ongoing study.
  • The webcast will be streamed via a link on the website: www.medivir.com/investors/presentations The presentation will be available on Medivir´s website after the webcast.

Global Aromatherapy Industry Assessment to 2028: Evolving Consumer Preferences for Natural Therapeutic Options - ResearchAndMarkets.com

Retrieved on: 
星期三, 八月 30, 2023
Home Goods, Luxury, Cosmetics, Retail, Specialty, Restless, Phobia, Inhalation, Depression, Anxiety, Prevalence, Plasma protein binding, B2B, Distribution (marketing), Statistics, COVID-19, Compound annual growth rate, Insomnia, Food, Aromatherapy, Traction, Investment, Pain management, Clifton Springs Hospital & Clinic, Growth, Relaxation, Skin, PTSD, Wound healing, Marketing, Medicinal plants

One of the pivotal driving forces behind the growth of the aromatherapy market is the escalating demand for natural products.

Key Points: 
  • One of the pivotal driving forces behind the growth of the aromatherapy market is the escalating demand for natural products.
  • Manufacturers of essential oils are focused on diversifying their aromatherapy product lines, a strategic move that is anticipated to boost the global aromatherapy market further.
  • This trajectory is closely aligned with evolving consumer preferences for natural products and shifts in therapeutic approaches.
  • With ongoing innovations, strategic geographic expansions, and evolving consumer preferences for natural therapeutic options, the global aromatherapy market is positioned to harness these trends and exhibit steady growth in the years ahead.

Global Cancer Microbiome Sequencing Market Landscape 2023-2027: Decreasing Sequencing Costs, Rise in Research & Development - ResearchAndMarkets.com

Retrieved on: 
星期二, 八月 29, 2023
Health, Oncology, Pacific Biosciences, QIAGEN, Prevalence, Biotechnology, Cancer, Diagnosis, Breast, Research, OraSure Technologies, Biomarker, Lung, Death, Incidence, Investment, Polymerase chain reaction, Clifton Springs Hospital & Clinic, Growth, WHO, Geography, Eurofins Scientific, Skin, World Health Organization, Oxford Nanopore Technologies, Software, Antibiotics, Medical imaging, Pharmaceutical industry, Illumina

The global cancer microbiome sequencing market is poised for remarkable growth during the forecast period from 2023 to 2027.

Key Points: 
  • The global cancer microbiome sequencing market is poised for remarkable growth during the forecast period from 2023 to 2027.
  • Decreasing Sequencing Costs: The cost of microbiome sequencing is reducing, making it more accessible for research and clinical applications.
  • Rise in Research & Development: Increasing research efforts aimed at understanding the impact of microbiomes on cancer have propelled the market.
  • Conclusion: With the convergence of growing cancer incidences, increasing awareness of microbiome contributions, and research advancements in sequencing technologies, the global cancer microbiome sequencing market is set for substantial growth.